Zoetis Inc. logo ZTS - Zoetis Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
1
BUY 14
HOLD 16
SELL 0
STRONG
SELL
0
| PRICE TARGET: $110.57 DETAILS
HIGH: $160.00
LOW: $85.00
MEDIAN: $99.00
CONSENSUS: $110.57
UPSIDE: 47.51%

About Zoetis Inc. (https://www.zoetis.com)

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

Key Executives

NAME TITLE DOB SALARY
Kristin C. Peck Chief Executive Officer & Director 1971 $5,421,697 USD
Wetteny N. Joseph Executive Vice President & Chief Financial Officer 1972 $1,796,941 USD
Jamie Brannan Executive Vice President & Chief Commercial Officer 1973 $1,742,448 USD
Robert J. Polzer Scientific Advisor 1969 $1,445,441 USD
Roxanne Lagano Executive Vice President, General Counsel & Corporate Secretary 1965 $1,435,587 USD
Abhay U. Nayak Executive VP & President of U.S. Commercial Operations 1988
Jared Shriver President of U.S. Operations
Jeannette Ferran Astorga Executive Vice President of Corporate Affairs & Chief Sustainability Officer 1976
Julie A. Fuller Executive Vice President, Chief Human Resources Officer & Global Operations 1973
Keith Sarbaugh Executive Vice President & Chief Digital and Technology Officer 1979
Nick Ashton Executive Vice President and President of Global Manufacturing & Supply 1974
Rimma Driscoll EVP of Global Strategy, Portfolio Mktg. & Business Dev and Global BioDevices & Platinum Performance 1973
Steven Frank Vice President of Investor Relations

Company Peers

Peer analysis pending, check back in 1-2 minutes.